| Stage | BLMN | % of rev | TCMD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.0B | 100.00% | $86M | 100.00% | BLMN ×11.85 |
| Gross profit | $397M | 39.06% | $65M | 76.25% | TCMD +37.2pp |
| Operating income | $38M | 3.77% | $7M | 7.97% | TCMD +4.2pp |
| Pre-tax income | $27M | 2.67% | $7M | 8.60% | TCMD +5.9pp |
| Net income | $33M | 3.21% | $8M | 9.08% | TCMD +5.9pp |
| Stage | BLMN | TCMD | Gap · A − B |
|---|---|---|---|
| Revenue | $1.0B100.00% | $86M100.00% | BLMN ×11.85 |
| Gross profit | 39.06%$397M | 76.25%$65M | TCMD +37.2pp |
| Operating income | 3.77%$38M | 7.97%$7M | TCMD +4.2pp |
| Pre-tax income | 2.67%$27M | 8.60%$7M | TCMD +5.9pp |
| Net income |
| 3.21%$33M |
| 9.08%$8M |
| TCMD +5.9pp |
None
No disclosed counterparties: BLMN.